Akshata Gujar

Q: What is Akshata Gujar email address?

Email Akshata Gujar at akshatadesai@gmail.com and akshata.gujar@novartis.com. This email is the most updated Akshata Gujar email found in 2026.

Q: How to contact Akshata Gujar?

To contact Akshata Gujar send an email to akshatadesai@gmail.com or akshata.gujar@novartis.com. (updated on October 30, 2024)

Principal Scientist I at Novartis | Pune, Maharashtra, India

About Akshata Gujar

Akshata Gujar serves as a Principal Scientist I at Novartis, where she brings 18 years of extensive experience in drug discovery and development, combining her expertise in both the pharmaceutical industry and academia. Her current focus lies in investigating the intricate mechanisms and signaling pathways involved in retinal degeneration diseases and glaucoma. By leveraging her deep understanding of human genetics and advanced molecular biology techniques, Akshata is at the forefront of developing innovative cell-based assays for target validation and elucidating the mechanisms of action (MOA) of potential therapeutic candidates.

In her role, Akshata actively contributes to project team meetings, where she presents rigorous scientific data and engages in strategic discussions that shape the research direction and project outcomes. Her ability to communicate complex scientific concepts clearly and effectively is instrumental in fostering a collaborative environment within her team. Additionally, she is dedicated to mentoring and training junior scientists, equipping them with essential skills in drug development methodologies, including CRISPR, qRT-PCR, fluorescence microscopy, RNA isolation, and transfection techniques.

Akshata's commitment to advancing the field of drug discovery is reflected in her hands-on approach to research and her passion for understanding the underlying genetic factors that contribute to disease. By integrating her expertise in genetics with cutting-edge technologies, she is poised to make significant contributions to the development of novel therapies aimed at combating retinal degeneration and glaucoma, ultimately improving patient outcomes in these challenging areas of medicine.

Akshata Gujar Work